News >

FDA Lifts Holds on 2 Nivolumab Myeloma Trials

Jason M. Broderick @jasoncology
Published: Wednesday, Dec 06, 2017

The FDA has lifted partial clinical holds placed on the phase I CheckMate-039 and phase II CA204142 trials exploring nivolumab-based regimens in patients with relapsed/refractory multiple myeloma.
... to read the full story
To Read the Full Story

View Conference Coverage
Online CME Activities
TitleExpiration DateCME Credits
Publication Bottom Border
Border Publication